11th Feb 2010 10:14
RNS Number : 0112H
AGI Therapeutics plc
11 February 2010
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 10 February 2010 that Edinburgh Partners Limited had decreased its shareholding to 2,569,576 Ordinary Shares representing 3.81% of AGI's Issued Share Capital.
On 11 February 2010 AGI was notified that Edinburgh Partners Limited no longer had a notifiable interest in AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai